MONOVISC is the new generation single injection viscosupplement with 4ml of highly purified, non-animal derived Hyaluronic Acid (HA). MONOVISC is also FDA & EU Approved.

Unique Features of MONOVISC are

  • High dose of Optimum Molecular Weight (88mg in 1 injection)
  • Application of Light Cross-Linked technology
  • Optimal Viscosity profile.

What is the efficacy for MONOVISC?

Monovisc provides pain relief as early as 2 weeks with faster and longer lasting pain relief up to 24 weeks compared to other competitor brand in the market.

What are the side effects?

  • Small & Transient Pain, warmth and slight swelling immediately after injection. (Note : ComfortPlus Hot/Cold Pack is provided to help ease the discomfort after injection.)
  • In clinical studies, the most commonly reported adverse events for MONOVISC were arthralgia, joint swelling and injection site pain.